| Multiple Sclerosis |
1 |
1 |
| Clinical Research |
0 |
0.97 |
| Diversity |
0 |
0.98 |
| Healthcare and Medical Technology |
0 |
0.36 |
| Social Determinants of Health |
0 |
0.99 |
| California |
0 |
0.19 |
| Disease-Modifying Therapy |
0 |
0.19 |
| Glatiramer Acetate |
0 |
0.19 |
| Literacy |
0 |
0.19 |
| Multiple Sclerosis Treatment |
0 |
0.96 |
| New York |
0 |
0.19 |
| Texas |
0 |
0.19 |
| Biologic Therapy |
0 |
0.07 |